Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Results of the implementation of an Antimicrobial Stewardship Program in the "Gerencia de Atención Integrada" of Alcazar de San Juan (Castilla La Mancha)].
Asencio Egea MA, Herráez Carrera O, Huertas Vaquero M, Patiño Ortega HD, Franco Huerta M, Alcázar Carmona P, Conde García MC, Muñoz-Cuevas C, Román Ortiz C, Gaitán Pitera J, Carranza González R, Barberá JR. Asencio Egea MA, et al. Among authors: barbera jr. Rev Esp Quimioter. 2018 Jun;31(3):247-256. Epub 2018 May 18. Rev Esp Quimioter. 2018. PMID: 29781595 Free PMC article. Spanish.
[Monoclonal spread of multi-drug resistant CTX-M-15-producing Klebsiella pneumoniae. Impact of measures to control the outbreak].
Asencio Egea MA, Huertas Vaquero M, Muñoz-Cuevas C, Gaitán Pitera J, Herráez Carrera O, Alcázar Carmona P, Patiño Ortega HD, Franco Huerta M, Román Ortiz C, Conde García MC, Carranza González R, Barberá JR, Bautista Sánchez V. Asencio Egea MA, et al. Among authors: barbera jr. Rev Esp Quimioter. 2018 Jun;31(3):237-246. Epub 2018 May 18. Rev Esp Quimioter. 2018. PMID: 29781594 Free PMC article. Spanish.
Effectiveness of direct-acting antiviral therapy in patients with a HCV/HIV coinfection. A multicenter cohort study.
Rial-Crestelo D, Rodríguez-Cola M, González-Gasca FJ, Geijo-Martínez P, Belinchón-Moya O, Martínez-Alfaro E, Mateos-Rodríguez F, Barberá JR, Yzusqui M, Casallo S, García M, Espinosa-Gimeno A, Torralba M. Rial-Crestelo D, et al. Among authors: barbera jr. Rev Esp Enferm Dig. 2018 Jan;110(1):35-43. doi: 10.17235/reed.2017.5210/2017. Rev Esp Enferm Dig. 2018. PMID: 29271221 Free article.
Impact of interferon-free therapies in HIV/HCV co-infected patients on real clinical practice: results from a multicenter region-wide cohort study (2014-2018).
Rial-Crestelo D, Sepúlveda MA, González-Gasca FJ, Geijo-Martínez P, Martínez-Alfaro E, Barberá JR, Yzusqui M, Casallo S, García M, Muñoz Hornero C, Espinosa-Gimeno A, Torralba M; Grupo de Estudio de Castilla la Manche de enfermedades Infecciosas (GECMEI). Rial-Crestelo D, et al. Among authors: barbera jr. Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):279-287. doi: 10.1097/MEG.0000000000002012. Eur J Gastroenterol Hepatol. 2021. PMID: 33252415
Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study.
Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Mayorga MI, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Casado A, Podzamczer D. Ocampo A, et al. Among authors: barbera jr. J Antimicrob Chemother. 2018 Aug 1;73(8):2171-2176. doi: 10.1093/jac/dky175. J Antimicrob Chemother. 2018. PMID: 29788066 Free article.
Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study.
Ruiz-Algueró M, Hernando V, Marcos H, Gutiérrez G, Pérez-Elías MJ, López-Bernaldo de Quirós JC, Pulido F, Górgolas M, Sanz J, Suarez-García I, Fernandez MT, Losa JE, Pérez JL, Ladrero MO, Prieto MÁ, González G, Izquierdo A, Viloria LJ, López I, Martínez E, Castrillejo D, Aranguren R, Belmonte MA, Aranda-García IV, Arraiza A, Diaz A; Hospital Survey Study Group. Ruiz-Algueró M, et al. BMC Infect Dis. 2021 Jan 30;21(1):129. doi: 10.1186/s12879-021-05815-3. BMC Infect Dis. 2021. PMID: 33516173 Free PMC article.
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm.
Artigas L, Coma M, Matos-Filipe P, Aguirre-Plans J, Farrés J, Valls R, Fernandez-Fuentes N, de la Haba-Rodriguez J, Olvera A, Barbera J, Morales R, Oliva B, Mas JM. Artigas L, et al. PLoS One. 2020 Oct 2;15(10):e0240149. doi: 10.1371/journal.pone.0240149. eCollection 2020. PLoS One. 2020. PMID: 33006999 Free PMC article.
18 results